Close Menu

NEW YORK (GenomeWeb) – Investment bank Cowen today initiated coverage of NanoString Technologies.

In a research note, analyst Doug Schenkel gave shares of NanoString an Outperform rating with a price target of $20 per share.

"We view the risk/reward as compelling given the track record, predictable growth model, and upside sources," he said.  Over the next two to five years, NanoString can generate sales growth "exceeding most other companies in the group, and the growth outlook is relatively predictable given the company's razor/blade model," Schenkel said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Associated Press reports that a state board in Texas has asked ANDE, a maker of rapid DNA machines, to halt its work there.

James Wyngaarden, the former director of the US National Institutes of Health, has died at 94, according to Duke University School of Medicine.

Researchers find that a 30-year-old skull comes from a narwhal-beluga hybrid, according to Science News.

In Nature this week: study of value diversity in GWAS, Epstein-Barr virus subtypes linked to nasopharyngeal carcinoma risk, and more.